NCT05240248

Optilene® Suture Material for Dermal Sutures

Assessment of Optilene® Suture Material for Skin Closure (Dermal Sutures). A Prospective Single-arm Observational Study in Daily Practice

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 172 (actual)
• Sponsor: Aesculap AG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

In this non-interventional study, Optilene® suture will be evaluated for skin closure in adult patients.

Detailed description

The study is designed as a prospective, unicentric and single-arm observational study to evaluate Optilene® suture material for skin closure. The product under investigation will be used in routine clinical practice and according to the Instructions for Use (IFU). After operation the investigator will examine the patients at discharge, at 10±5 days after surgery (removal of the suture) and 30±10 days postoperatively.

Conditions

• Laceration
• Incision

Timeline

• Start date: 2022-06-22
• Primary completion: 2023-06-23
• Completion: 2023-07-23
• First posted: 2022-02-15
• Last updated: 2024-02-21

Locations

1 site across 1 country: Spain